TAG to Honor Leaders of Latino HIV Community, Pediatric Drug-Resistant TB, and Transgender Health at RIAA 2023
HCV Elimination Among People Living with and at Risk of HIV: Challenges and Opportunities
Letter to Dr. Jeanne Marazzo, New Director NIAID
TAG Welcomes Addition of Ravidasvir to WHO Essential Medicines List for Treatment of Hepatitis C Virus
Open letter: Requesting Clarification on the Recent Deal on Generic Bedaquiline Supply
Employee Engagement Programs & Affinity Groups: Partner with TAG to Drive Social Impact
At Treatment Action Group (TAG), we recognize the immense potential of collective action in bringing about positive change. That's why we invite companies and organizations to join us in the fight against HIV, hepatitis C (HCV), and tuberculosis (TB) through…
Celebrate and Expand Your Support: Leverage the Power of Your Networks and Social Media
At Treatment Action Group (TAG), we believe in the power of social media to amplify support and spread awareness. By utilizing social media platforms and online communities, you can celebrate your special occasions while expanding your impact and raising awareness…
Join TAG’s Board: Shape the Future of Health Advocacy
Treatment Action Group (TAG) is seeking passionate individuals committed to ending the epidemics of HIV, hepatitis C (HCV), and tuberculosis (TB) to join our oard of directors. As a member of TAG's Board, you will play a pivotal role in…
Donor Advised Funds: Amplify Your Impact with Treatment Action Group
Supporting Treatment Action Group (TAG) through Donor Advised Funds (DAFs) empowers you to maximize the impact of your philanthropy. A Donor Advised Fund is a flexible giving vehicle that allows you to make a charitable contribution, receive an immediate tax…